AstraZeneca: Clearing confusion – vaccine effectiveness

Vaxzevria, AstraZeneca's viral vector COVID-19 vaccine, launched a campaign in Asia to generate region-specific, scientifically credible evidence, expose vaccine programme decision makers to evidence, and change the media discussion from antibodies to outcomes.

The problem

An incorrect picture of 'mRNA' COVID-19 vaccines being more effective than 'viral vector' COVID-19 vaccines was forming across APAC.

We readied to overcome a threat to vaccine trust

Earlier this year, Vaxzevria,AstraZeneca's 'viral vector' COVID-19...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today